Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.180
+0.050 (1.60%)
Nov 21, 2024, 4:00 PM EST - Market closed

Zentalis Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Revenue
40.56-----
Upgrade
Gross Profit
40.56-----
Upgrade
Selling, General & Admin
63.4859.454.5540.9433.898.46
Upgrade
Research & Development
186.35189.59172.73166.884.938.39
Upgrade
Operating Expenses
249.83248.99227.29207.74118.7946.85
Upgrade
Operating Income
-209.27-248.99-227.29-207.74-118.79-46.85
Upgrade
Interest & Investment Income
11.19.462.261.311.240.48
Upgrade
Earnings From Equity Investments
--16.01-16.28-1.83--
Upgrade
EBT Excluding Unusual Items
-198.17-255.54-241.31-208.26-117.55-46.36
Upgrade
Gain (Loss) on Sale of Investments
19.0813.163.73-0.91-0.56-
Upgrade
Gain (Loss) on Sale of Assets
---51.58--
Upgrade
Asset Writedown
--4.95--8.8--
Upgrade
Pretax Income
-179.09-292.91-237.58-166.39-118.1-46.36
Upgrade
Income Tax Expense
0.25-0.6-0.47-0.30.440.02
Upgrade
Earnings From Continuing Operations
-179.33-292.31-237.11-166.09-118.55-46.38
Upgrade
Minority Interest in Earnings
0.050.110.317.370.710.72
Upgrade
Net Income
-179.28-292.19-236.81-158.73-117.84-45.66
Upgrade
Net Income to Common
-179.28-292.19-236.81-158.73-117.84-45.66
Upgrade
Shares Outstanding (Basic)
71655343286
Upgrade
Shares Outstanding (Diluted)
71655343286
Upgrade
Shares Change (YoY)
14.04%23.75%23.82%51.84%402.29%0.05%
Upgrade
EPS (Basic)
-2.53-4.47-4.48-3.72-4.19-8.16
Upgrade
EPS (Diluted)
-2.53-4.47-4.48-3.72-4.19-8.16
Upgrade
Free Cash Flow
-172.15-208.41-166.3-160.2-87.58-39.5
Upgrade
Free Cash Flow Per Share
-2.43-3.19-3.15-3.75-3.12-7.06
Upgrade
Gross Margin
100.00%-----
Upgrade
Operating Margin
-515.94%-----
Upgrade
Profit Margin
-442.02%-----
Upgrade
Free Cash Flow Margin
-424.44%-----
Upgrade
EBITDA
-207.96-247.6-225.86-207.2-118.63-46.73
Upgrade
D&A For EBITDA
1.311.391.430.540.160.11
Upgrade
EBIT
-209.27-248.99-227.29-207.74-118.79-46.85
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.